(Q72001785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

High doses of aminoglycosides did not produce liver toxicity in patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

A Lindblad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

R Hultcrantz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

B Strandvik

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 February 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

201-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Early effects of gentamicin, tobramycin, and amikacin on the human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Prospective evaluation of liver function tests in patients treated with aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Practical stereological methods for morphometric cytology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Sclerosing cholangitis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Pseudomonas aeruginosa exotoxin in mice: histopathology and serum enzyme changes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

Stereology of liver biopsies from healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980058-3

7 January 2021

10.1016/S0168-8278(05)80058-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8006400%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference